489 related articles for article (PubMed ID: 27241369)
21. [Prolonged treatment with dalbavancin in prosthetic hip infection by methicillin-resistant Staphylococcus epidermidis].
Trujillano Ruiz A; Mesquida Riera J; Serrano Fabiá MA; Riera Pérez E; Mejía Benard A; Taberner Ferrer MD
Rev Esp Quimioter; 2019 Apr; 32(2):203-204. PubMed ID: 30868837
[No Abstract] [Full Text] [Related]
22. Anti-biofilm activity of dalbavancin against methicillin-resistant
Silva V; Miranda C; Bezerra M; Antão HS; Guimarães J; Prada J; Pires I; Maltez L; Pereira JE; Capelo JL; Igrejas G; Poeta P
J Chemother; 2021 Nov; 33(7):469-475. PubMed ID: 33904369
[TBL] [Abstract][Full Text] [Related]
23. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.
Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ
Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222
[TBL] [Abstract][Full Text] [Related]
24. In vitro time-kill kinetics of dalbavancin against Staphylococcus spp. biofilms over prolonged exposure times.
Di Pilato V; Ceccherini F; Sennati S; D'Agostino F; Arena F; D'Atanasio N; Di Giorgio FP; Tongiani S; Pallecchi L; Rossolini GM
Diagn Microbiol Infect Dis; 2020 Feb; 96(2):114901. PubMed ID: 31761480
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial susceptibility and biofilm formation of Staphylococcus epidermidis small colony variants associated with prosthetic joint infection.
Maduka-Ezeh AN; Greenwood-Quaintance KE; Karau MJ; Berbari EF; Osmon DR; Hanssen AD; Steckelberg JM; Patel R
Diagn Microbiol Infect Dis; 2012 Nov; 74(3):224-9. PubMed ID: 22901790
[TBL] [Abstract][Full Text] [Related]
26. Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci.
Neudorfer K; Schmidt-Malan SM; Patel R
Diagn Microbiol Infect Dis; 2018 Jan; 90(1):58-63. PubMed ID: 29195766
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases.
Nishimura S; Tsurumoto T; Yonekura A; Adachi K; Shindo H
J Orthop Sci; 2006 Jan; 11(1):46-50. PubMed ID: 16437348
[TBL] [Abstract][Full Text] [Related]
28. Metabolic activity, urease production, antibiotic resistance and virulence in dual species biofilms of Staphylococcus epidermidis and Staphylococcus aureus.
Vandecandelaere I; Van Nieuwerburgh F; Deforce D; Coenye T
PLoS One; 2017; 12(3):e0172700. PubMed ID: 28263995
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.
Hamad T; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
APMIS; 2015 Dec; 123(12):1055-60. PubMed ID: 26547372
[TBL] [Abstract][Full Text] [Related]
30. Relationship between autolysis and teicoplanin activity against Staphylococcus epidermidis.
Batard E; Amirault E; Caroff N; Asseray N; Caillon J; Potel G
Int J Antimicrob Agents; 2010 Dec; 36(6):574-5. PubMed ID: 20869851
[No Abstract] [Full Text] [Related]
31. Rhodomyrtus tomentosa (Aiton) Hassk. ethanol extract and rhodomyrtone: a potential strategy for the treatment of biofilm-forming staphylococci.
Saising J; Ongsakul M; Voravuthikunchai SP
J Med Microbiol; 2011 Dec; 60(Pt 12):1793-1800. PubMed ID: 21816945
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013).
Huband MD; Castanheira M; Farrell DJ; Flamm RK; Jones RN; Sader HS; Mendes RE
Int J Antimicrob Agents; 2016 Jun; 47(6):495-9. PubMed ID: 27211209
[TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro activities of dalbavancin and seven comparator agents against 41 Staphylococcus species cultured from osteomyelitis infections and 18 VISA and hVISA strains.
Citron DM; Tyrrell KL; Goldstein EJ
Diagn Microbiol Infect Dis; 2014 Aug; 79(4):438-40. PubMed ID: 24972854
[TBL] [Abstract][Full Text] [Related]
34.
Delpech G; Ceci M; Lissarrague S; García Allende L; Baldaccini B; Sparo M
Biofouling; 2020 Mar; 36(3):266-275. PubMed ID: 32338055
[No Abstract] [Full Text] [Related]
35. Comparison of Staphylococcus epidermidis isolated from prosthetic joint infections and commensal isolates in regard to antibiotic susceptibility, agr type, biofilm production, and epidemiology.
Hellmark B; Söderquist B; Unemo M; Nilsdotter-Augustinsson Å
Int J Med Microbiol; 2013 Jan; 303(1):32-9. PubMed ID: 23245829
[TBL] [Abstract][Full Text] [Related]
36. Staphylococcus aureus and Staphylococcus epidermidis infections on implants.
Oliveira WF; Silva PMS; Silva RCS; Silva GMM; Machado G; Coelho LCBB; Correia MTS
J Hosp Infect; 2018 Feb; 98(2):111-117. PubMed ID: 29175074
[TBL] [Abstract][Full Text] [Related]
37. Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis.
Kussmann M; Karer M; Obermueller M; Schmidt K; Barousch W; Moser D; Nehr M; Ramharter M; Poeppl W; Makristathis A; Winkler S; Thalhammer F; Burgmann H; Lagler H
Emerg Microbes Infect; 2018 Dec; 7(1):202. PubMed ID: 30514923
[TBL] [Abstract][Full Text] [Related]
38. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
[TBL] [Abstract][Full Text] [Related]
39. [Methicillin resistant staphylococci].
Afanas'eva TI
Antibiot Khimioter; 1998; 43(6):29-31. PubMed ID: 9644532
[No Abstract] [Full Text] [Related]
40. Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):177-84. PubMed ID: 19249179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
